PortfoliosLab logoPortfoliosLab logo
ASPI vs. AYTU
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ASPI vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ASP Isotopes Inc. Common Stock (ASPI) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ASPI vs. AYTU - Yearly Performance Comparison


2026 (YTD)2025202420232022
ASPI
ASP Isotopes Inc. Common Stock
-17.38%18.10%153.07%13.29%-40.82%
AYTU
Aytu BioPharma, Inc.
5.00%52.94%-40.14%-24.87%18.42%

Fundamentals

Market Cap

ASPI:

$391.40M

AYTU:

$27.40M

EPS

ASPI:

-$1.31

AYTU:

-$2.02

PS Ratio

ASPI:

42.59

AYTU:

0.53

PB Ratio

ASPI:

5.28

AYTU:

1.93

Total Revenue (TTM)

ASPI:

$8.38M

AYTU:

$62.64M

Gross Profit (TTM)

ASPI:

$1.93M

AYTU:

$41.34M

EBITDA (TTM)

ASPI:

-$106.65M

AYTU:

-$17.24M

Returns By Period

In the year-to-date period, ASPI achieves a -17.38% return, which is significantly lower than AYTU's 5.00% return.


ASPI

1D
4.74%
1M
-17.23%
YTD
-17.38%
6M
-54.05%
1Y
-5.76%
3Y*
72.99%
5Y*
10Y*

AYTU

1D
3.61%
1M
6.23%
YTD
5.00%
6M
45.21%
1Y
127.50%
3Y*
6.82%
5Y*
-55.20%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASPI vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASPI
ASPI Risk / Return Rank: 4444
Overall Rank
ASPI Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
ASPI Sortino Ratio Rank: 4848
Sortino Ratio Rank
ASPI Omega Ratio Rank: 4545
Omega Ratio Rank
ASPI Calmar Ratio Rank: 4343
Calmar Ratio Rank
ASPI Martin Ratio Rank: 4343
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 8686
Overall Rank
AYTU Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 9292
Sortino Ratio Rank
AYTU Omega Ratio Rank: 9090
Omega Ratio Rank
AYTU Calmar Ratio Rank: 8585
Calmar Ratio Rank
AYTU Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASPI vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ASP Isotopes Inc. Common Stock (ASPI) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ASPIAYTUDifference

Sharpe ratio

Return per unit of total volatility

-0.06

1.09

-1.14

Sortino ratio

Return per unit of downside risk

0.72

3.01

-2.29

Omega ratio

Gain probability vs. loss probability

1.08

1.39

-0.31

Calmar ratio

Return relative to maximum drawdown

0.08

2.96

-2.88

Martin ratio

Return relative to average drawdown

0.15

7.81

-7.67

ASPI vs. AYTU - Sharpe Ratio Comparison

The current ASPI Sharpe Ratio is -0.06, which is lower than the AYTU Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of ASPI and AYTU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ASPIAYTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.06

1.09

-1.14

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.65

Sharpe Ratio (All Time)

Calculated using the full available price history

0.15

-0.36

+0.50

Correlation

The correlation between ASPI and AYTU is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ASPI vs. AYTU - Dividend Comparison

Neither ASPI nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ASPI vs. AYTU - Drawdown Comparison

The maximum ASPI drawdown since its inception was -88.57%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for ASPI and AYTU.


Loading graphics...

Drawdown Indicators


ASPIAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-88.57%

-100.00%

+11.43%

Max Drawdown (1Y)

Largest decline over 1 year

-70.00%

-42.47%

-27.53%

Max Drawdown (5Y)

Largest decline over 5 years

-99.34%

Current Drawdown

Current decline from peak

-68.54%

-100.00%

+31.46%

Average Drawdown

Average peak-to-trough decline

-40.72%

-95.05%

+54.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

38.07%

16.07%

+22.00%

Volatility

ASPI vs. AYTU - Volatility Comparison

ASP Isotopes Inc. Common Stock (ASPI) has a higher volatility of 28.17% compared to Aytu BioPharma, Inc. (AYTU) at 9.71%. This indicates that ASPI's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ASPIAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

28.17%

9.71%

+18.46%

Volatility (6M)

Calculated over the trailing 6-month period

77.47%

39.38%

+38.09%

Volatility (1Y)

Calculated over the trailing 1-year period

105.26%

117.87%

-12.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

111.58%

85.83%

+25.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.58%

190.04%

-78.46%

Financials

ASPI vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between ASP Isotopes Inc. Common Stock and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
4.89M
15.17M
(ASPI) Total Revenue
(AYTU) Total Revenue
Values in USD except per share items